Mark Lightowler

Views & Analysis

Bad behaviour: why understanding human behaviour can improve...

Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour.

Views & Analysis

Is behavioural science the new capability every pharma company should be building

Behaviour science: the new capability every pharma company s...

Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.

Views & Analysis

How behavioural science is helping in the fight against COVI...

Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of changing how we live.

Bad behaviour: why understanding human behaviour can improve...

Behaviour science: the new capability every pharma company s...

How behavioural science is helping in the fight against COVI...

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks